psalexa
SearchBar Icon

Biosimilars Market By Product (Recombinant Glycosylated Proteins [Monoclonal Antibodies, Erythropoietin, Follitropin], Recombinant Non-Glycosylated Proteins [Insulin, Recombinant Human Growth Hormone, Granulocyte-Colony Stimulating Factor, Interferons], Recombinant Peptides), By Technology (Monoclonal Antibody, Recombinant DNA, Bioassays, Nuclear Magnetic Resonance, Electrophoresis), By Indication (Oncology, Rheumatology, Blood-Related Disorders, Auto-Immune Diseases, Chronic Diseases, Infectious Diseases, Growth Hormone Deficiency), By Manufacturing Type (Contract, In-House), By Route of Administration (Intravenous, Subcutaneous, Intranasal), by Geography (Germany, France, U.K., Italy, Spain, Sweden, Russia, Switzerland, Austria, Netherlands, Belgium, Norway, China, Japan, India, South Korea, Singapore, Australia, Thailand, Indonesia, Malaysia, U.S., Canada, Brazil, Mexico, Argentina, Columbia, U.A.E., Israel, South Africa, Saudi Arabia) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2014–2024

Biosimilars Market (2014-2024)
Published:  April 2019 Report Code:  LS10997 Available Format:   Pages:  187
Plane  Enquire Before Purchase
Place an order
alert The report will be delivered in PDF format without printing rights. It is recommended for a single user.
USD 5100
alert The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.
USD 6100
alert The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.
USD 9150